Lipid-lowering therapy use and achievement of cholesterol targets in an Australian diabetes clinic-Reference-Cited by-同舟云学术

Lipid-lowering therapy use and achievement of cholesterol targets in an Australian diabetes clinic

Published:2018-02 Issue:2 Volume:48 Page:201-204
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Intern Med J

Author:

Kiburg Katerina V.¹²^ORCID,Ward Glenn M.¹³,O’Neal David N.¹³,MacIsaac Richard J.¹³

Affiliation:

1. Department of Endocrinology and Diabetes; St Vincent’s Hospital Melbourne; Melbourne Victoria Australia

2. Department of Endocrinology and Diabetes; St Vincent’s Institute of Medical Research; Melbourne Victoria Australia

3. Department of Medicine; University of Melbourne; Melbourne Victoria Australia

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/imj.13691/fullpdf

Reference20 articles.

1. Review of clinical practice guidelines for the management of LDL-related risk;Morris;J Am Coll Cardiol,2014

2. Locally weighted regression: an approach to regression analysis by local fitting;Cleveland;J Am Stat Assoc,1988

3. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Pederson;Lancet,1994

4. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial;Colhoun;Lancet,2004

5. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial;Ridker;Lancet,2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temporal trends in non-traumatic lower extremity amputations (LEAs) and their association with 12-month mortality in people with diabetes, 2004–2016;Journal of Diabetes and its Complications;2022-07